0001104659-21-100781.txt : 20210805 0001104659-21-100781.hdr.sgml : 20210805 20210805162326 ACCESSION NUMBER: 0001104659-21-100781 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20210805 ITEM INFORMATION: Other Events ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20210805 DATE AS OF CHANGE: 20210805 FILER: COMPANY DATA: COMPANY CONFORMED NAME: OMEGA HEALTHCARE INVESTORS INC CENTRAL INDEX KEY: 0000888491 STANDARD INDUSTRIAL CLASSIFICATION: REAL ESTATE INVESTMENT TRUSTS [6798] IRS NUMBER: 383041398 STATE OF INCORPORATION: MD FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-11316 FILM NUMBER: 211148608 BUSINESS ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 BUSINESS PHONE: 410-427-1700 MAIL ADDRESS: STREET 1: 303 INTERNATIONAL CIRCLE, STREET 2: SUITE 200 CITY: HUNT VALLEY STATE: MD ZIP: 21030 8-K 1 tm2124195d1_8k.htm FORM 8-K
0000888491 false 0000888491 2021-08-05 2021-08-05 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

 

FORM 8-K

 

 

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): August 5, 2021

 

OMEGA HEALTHCARE INVESTORS, INC.

(Exact name of registrant as specified in its charter)

 

Maryland 1-11316 38-3041398
(State or other jurisdiction of
incorporation)
(Commission File Number)

(IRS Employer

Identification No.)

 

303 International Circle

Suite 200

Hunt Valley, Maryland 21030

(Address of principal executive offices / Zip Code)

 

(410) 427-1700

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

  ¨ Written communications pursuant to Rule 425 under the Securities Act.

 

  ¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act.

 

  ¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.

 

  ¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.

 

Securities registered pursuant to Section 12(b) of the Securities Exchange Act of 1934:

 

     
Title of each class Trading Symbol(s) Name of each exchange on which registered
Common Stock, $.10 par value OHI New York Stock Exchange

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

 

 

 

 

Item 8.01Other Events.

 

On August 5, 2021, Omega Healthcare Investors, Inc. (the “Company”) filed a prospectus supplement (the “Prospectus Supplement”) relating to the Company’s existing Dividend Reinvestment and Common Stock Purchase Plan (the “Plan”), under the Company’s existing universal shelf registration statement on Form S-3 (File No. 333-256084) filed on May 13, 2021. The Prospectus Supplement continues the offering of shares of the Company’s common stock, par value $0.10 per share (the “Common Stock”) under the Plan previously covered by a prospectus supplement filed January 2, 2020 under the Company’s universal shelf registration statement on Form S-3 (Registration No. 333-227148) filed on August 31, 2018 and expiring August 31, 2021, and prior thereto under a registration statement on Form S-3 (File No. 333-215424) filed January 4, 2017. The Plan is designed to provide the Company’s existing stockholders and interested new investors with a method of purchasing Common Stock and investing all or a percentage of their cash dividends in additional shares of Common Stock.

 

Attached as Exhibit 5.1 to this Current Report on Form 8-K is a copy of the opinion of Shapiro Sher Guinot & Sandler, P.A. regarding certain Maryland law matters, including the validity of the Common Stock offered pursuant to the Prospectus Supplement. Attached as Exhibit 8.1 to this Current Report on Form 8-K is a copy of the opinion of Bryan Cave Leighton Paisner LLP regarding certain tax matters in connection with the Prospectus Supplement.

 

This Current Report on Form 8-K shall not constitute an offer to sell or a solicitation of an offer to buy any securities, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or other jurisdiction.

 

Item 9.01Financial Statements and Exhibits

 

(d) Exhibits

 

Exhibit No.  Description of Exhibit
5.1  Opinion of Shapiro Sher Guinot & Sandler, P.A.
8.1  Opinion of Bryan Cave Leighton Paisner LLP
23.1  Consent of Shapiro Sher Guinot & Sandler P.A. (included in Exhibit 5.1)
23.2  Consent of Bryan Cave Leighton Paisner LLP (included in Exhibit 8.1)
104  Cover Page Interactive Data File (embedded within the Inline XBRL document).

 

2

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  OMEGA HEALTHCARE INVESTORS, INC.
     
Dated: August 5, 2021 By: /s/ Robert O. Stephenson
    Robert O. Stephenson
    Chief Financial Officer, Treasurer and Assistant Secretary

 

 

EX-5.1 2 tm2124195d1_ex5-1.htm EXHIBIT 5.1

Exhibit 5.1

 

August 5, 2021

 

 

Omega Healthcare Investors, Inc.

303 International Circle

Suite 200

Hunt Valley, Maryland 21030

 

Re: Omega Healthcare Investors, Inc.
  Registration Statement on Form S-3 (File No. 333-256084)
  Dividend Reinvestment and Common Stock Purchase Plan

 

Ladies and Gentlemen:

 

We have served as Maryland counsel to Omega Healthcare Investors, Inc., a Maryland corporation (the “Company”), in connection with certain matters of Maryland law arising out of the registration by the Company of the offering and sale of up to 8,341,183 shares (the “Shares”) of the Company’s common stock, par value $0.10 per share (the “Common Stock”), covered by the above-referenced Registration Statement, and all amendments thereto (the “Registration Statement”), filed by the Company with the United States Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “1933 Act”). The Shares are to be issued pursuant to the Company’s Dividend Reinvestment and Common Stock Purchase Plan (as amended, the “Plan”). We understand that Bryan Cave Leighton Paisner LLP is providing you with an opinion regarding the Company and certain tax matters.

 

I. Documents Reviewed and Matters Considered

 

In connection with our representation of the Company, and as a basis for the opinions hereinafter set forth, we have examined originals, or copies certified or otherwise identified to our satisfaction, of the following documents (herein collectively referred to as the “Documents”):

 

(i)      the Plan;

 

(ii)     the Registration Statement, and the related form of prospectus included therein, in the form in which it was transmitted to the Commission under the 1933 Act;

 

 

 

Omega Healthcare Investors, Inc.

 

August 5, 2021

Page 2

 

(iii)    the Prospectus Supplement, dated as of August 5, 2021 (the “Prospectus Supplement”);

 

(iv)    the charter of the Company (the “Charter”), certified by the State Department of Assessments and Taxation of Maryland (the “SDAT”);

 

(v)     the Amended and Restated Bylaws of the Company (the “Bylaws”), certified as of the date hereof by an officer of the Company;

 

(vi)    a Certificate of Status of the SDAT to the effect that the Company is in good standing, dated August 3, 2021;

 

(vii)   resolutions adopted by the Board of Directors of the Company relating to, among other matters, the issuance of the Shares and the moving of the Plan to the Registration Statement (the “Resolutions”), certified as of the date hereof by an officer of the Company;

 

(viii)  a certificate executed by an officer of the Company, dated as of the date hereof; and

 

(ix)     such other documents and matters as we have deemed necessary or appropriate to express the opinions set forth below, subject to the assumptions, limitations and qualifications stated herein.

 

II. Assumptions

 

In expressing the opinions set forth below, we have assumed the following:

 

(a)      Each individual executing any of the Documents, whether on behalf of such individual or another person, is legally competent to do so.

 

(b)      Each individual executing any of the Documents on behalf of a party (other than the Company) is duly authorized to do so.

 

(c)      Each of the parties (other than the Company) executing any of the Documents has duly and validly executed and delivered each of the Documents to which such party is a signatory, and such party’s obligations set forth therein are legal, valid and binding and are enforceable in accordance with all stated terms.

 

 

 

Omega Healthcare Investors, Inc.

 

August 5, 2021

Page 3

 

(d)     All Documents submitted to us as originals are authentic. The form and content of all Documents submitted to us as unexecuted drafts do not differ in any respect relevant to this opinion from the form and content of such Documents as executed and delivered.

 

(e)     All Documents submitted to us as certified or photostatic copies conform to the original documents. All signatures on all Documents are genuine. All public records reviewed or relied upon by us or on our behalf are true and complete. All representations, warranties, statements and information contained in the Documents are true and complete. There has been no oral or written modification of or amendment to any of the Documents, and there has been no waiver of any provision of any of the Documents, by action or omission of the parties or otherwise.

 

(f)      Upon the issuance of any of the Shares, the total number of shares of Common Stock issued and outstanding will not exceed the total number of shares of Common Stock that the Company is then authorized to issue under the Charter.

 

(g)     The Shares will not be issued or transferred in violation of any restriction on transfer and ownership of shares of the Company set forth in the Charter.

 

III. Opinions

 

Based upon the foregoing, and subject to the assumptions, limitations and qualifications stated herein, it is our opinion that:

 

1.       The Company is a corporation duly incorporated and validly existing under and by virtue of the laws of the State of Maryland and is in good standing with the SDAT.

 

2.       The issuance of the Shares by the Company has been duly authorized and, when and if issued and delivered in accordance with the Resolutions, the Registration Statement, the Prospectus Supplement, and the Plan, the Shares will be validly issued, fully paid and nonassessable.

 

IV. Qualifications and Limitations

 

(A)    The foregoing opinions are limited to the laws of the State of Maryland and we do not express any opinion herein concerning any other law. We express no opinion as to the applicability or effect of federal or state securities laws, including the securities laws of the State of Maryland, or as to federal or state laws regarding fraudulent transfers. To the extent that any matter as to which our opinion is expressed herein would be governed by the laws of any jurisdiction other than the State of Maryland, we do not express any opinion on such matter. The opinions expressed herein are subject to the effect of judicial decisions which may permit the introduction of parol evidence to modify the terms or the interpretation of agreements.

 

 

 

Omega Healthcare Investors, Inc.

 

August 5, 2021

Page 4

 

(B)     The opinions expressed herein are limited to the matters specifically set forth herein and no other opinions shall be inferred beyond the matters expressly stated. We assume no obligation to supplement this opinion letter if any applicable law changes after the date hereof or if we become aware of any fact that might change the opinions expressed herein after the date hereof.

 

(C)     This opinion is being furnished to you for submission to the Commission as an exhibit to the Company’s Current Report on Form 8-K relating to the issuance of the Shares (the “Current Report”), which is incorporated by reference in the Registration Statement. We hereby consent to the filing of this opinion as an exhibit to the Current Report and the said incorporation by reference and to the use of the name of our firm therein. In giving this consent, we do not admit that we are within the category of persons whose consent is required by Section 7 of the 1933 Act.

 

 

  Very truly yours,
   
   
  /s/ SHAPIRO SHER GUINOT & SANDLER, P.A.

 

EX-8.1 3 tm2124195d1_ex8-1.htm EXHIBIT 8.1

Exhibit 8.1

 

August 5, 2021

 

Omega Healthcare Investors, Inc.
303 International Circle
Suite 200
Hunt Valley, Maryland 21030

 

 

Re:Dividend Reinvestment and Common Stock Purchase Plan – Certain Material Federal Income Tax Matters

 

Ladies and Gentlemen:

 

You have requested our opinion concerning certain material United States federal income tax considerations in connection with the registration by Omega Healthcare Investors, Inc., a Maryland corporation (the “Company”), of the offering and sale of up to 8,341,183 shares of common stock, par value $0.10 per share (the “Shares”), as more fully described in the Registration Statement, as amended (the “Registration Statement,” which includes the Prospectus), on Form S-3 (File No. 333-256084) as filed with the Securities and Exchange Commission (the “SEC”) on May 13, 2021 and the Prospectus Supplement (the “Prospectus Supplement”) as filed with the SEC on the date hereof. The Shares are to be issued pursuant to the Company’s Dividend Reinvestment and Common Stock Purchase Plan, as amended.

 

In rendering our opinion, we have examined and relied on originals or copies certified or otherwise identified to our satisfaction of (i) the Articles of Incorporation, the Articles of Amendment, Articles of Amendment and Restatement, and Articles Supplementary thereto, of the Company and its subsidiaries (ii) the Registration Statement and the Prospectus Supplement, and (iii) such other documents, certificates, and records as we have deemed necessary or appropriate. We also have relied upon factual statements and representations made to us by representatives of the Company that are set forth in a certificate executed and provided to us by the Company (the “Officers’ Certificate”). With respect to the ownership of stock of the Company for certain periods prior to March 8, 2004, we also have relied on a letter from Explorer Holdings, L.P., regarding the ownership of stock of the Company by Explorer Holdings, L.P., Explorer Holdings Level II, L.P., and Hampstead Investment Partners III, L.P. For purposes of this opinion, we have assumed, without independently verifying the facts, the validity and accuracy of the documents, certificates and records set forth above, and that the statements and representations made therein are and will remain true and complete. We also have assumed that the Registration Statement, the Prospectus Supplement and such other documents, certificates and records and that the statements as to factual matters contained in the Registration Statement and the Prospectus Supplement are true, correct and complete and will continue to be true, correct and complete through the completion of the transactions contemplated therein. For purposes of this opinion, we have not, however, assumed the correctness of any statement to the effect that the Company qualifies as a real estate investment trust (“REIT”) under the Internal Revenue Code of 1986, as amended (the “Code”), and the rules and regulations promulgated thereunder (the “Regulations”).

 

 

 

In our examination, we have assumed the legal capacity of all natural persons, the genuineness of all signatures, the authenticity of all documents submitted to us as originals, the conformity to original documents of all documents submitted to us as certified, conformed or photo copies, and the authenticity of the originals of such copies, or by facsimile or other means of electronic transmission, or which we obtained from the SEC’s Electronic Data Gathering, Analysis and Retrieval system (“EDGAR”) or other sites maintained by a court or governmental authority or regulatory body and the authenticity of the originals of such latter documents. If any documents we examined in printed, word processed or similar form has been filed with the SEC on EDGAR or other such sites maintained by a court or governmental authority or regulatory body, we have assumed that the document so filed is identical to the document we examined except for formatting changes. In making our examination of documents executed, or to be executed, by the parties indicated therein, we have assumed that each party (other than the Company) has, or will have, the power, corporate or other, to enter into and perform all obligations thereunder and we have also assumed the due authorization by all requisite action, corporate or other, and the execution and delivery by such parties and the validity and binding effect thereof on such parties. All of the documents we have reviewed will be complied with without waiver. Finally, in connection with the opinions rendered below, we have assumed that during its taxable year ended December 31, 1992, and in each subsequent taxable year to present, the Company has operated and will continue to operate in such a manner that makes and will continue to make the representations contained in the Officers’ Certificate true for each of such years, as of the date hereof, and any representation made as a belief, made “to the knowledge of,” or made in a similarly qualified manner is true, correct, and complete, as of the date hereof, without such qualification.

 

In rendering our opinion, we have considered the applicable provisions of the Code, the Regulations, pertinent judicial authorities, interpretive rulings of the Internal Revenue Service and such other authorities as we have considered relevant, all in effect as of the date hereof. It should be noted that statutes, regulations, judicial decisions and administrative interpretations are subject to change at any time (possibly with retroactive effect). A change in the authorities or the accuracy or completeness of any of the information, documents, certificates, records, statements, representations, covenants, or assumptions on which our opinion is based could affect our conclusions.

 

Based on the foregoing, in reliance thereon and subject thereto and to the limitations stated below, it is our opinion that:

 

1.From and including the Company’s taxable year ended December 31, 1992, the Company was and is organized in conformity with the requirements for, its actual methods of operation through the date hereof have permitted, and its proposed methods of operations as described in the Registration Statement, Prospectus Supplement and Officers’ Certificate will permit the Company to meet the requirements for, qualification and taxation as a REIT under the Code, and the Company has qualified and will so qualify, and the Company will continue to meet such requirements and qualify as a REIT after consummation of the contemplated transactions and the application of the proceeds, if any, from the offering of the Shares by the Company as described in the Registration Statement and the Prospectus Supplement; and

 

 

 

2.The discussion in the Registration Statement in the section entitled “MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS,” as supplemented by the discussion in the Prospectus Supplement under the heading “ADDITIONAL MATERIAL U.S. FEDERAL INCOME TAX CONSIDERATIONS,” insofar as such statements constitute a summary of U.S. federal tax matters, taken together, fairly and accurately summarizes such matters in all material respects.

 

The Company’s qualification and taxation as a REIT depend upon the Company’s ability to meet on a continuing basis, through actual annual operating and other results, the various requirements under the Code with regard to, among other things, the sources of its gross income, the composition of its assets, the level of its distributions to stockholders, the diversity of its stock ownership, and various other qualification tests imposed under the Code. We will not review the Company’s compliance with these requirements on a continuing basis. Accordingly, no assurance can be given that the actual results of the operations of the Company and its subsidiaries, the sources of their income, the nature of their assets, the level of the Company’s distributions to stockholders, and the diversity of its stock ownership for any given taxable year will satisfy the requirements for qualification and taxation as a REIT under the Code and conform to the representations in the Officers’ Certificate.

 

Except as set forth above, we express no opinion to any party as to the tax consequences, whether federal, state, local or foreign, of the offerings discussed in the Registration Statement or of any transaction related thereto or contemplated thereby. We consent to the filing of this opinion as an exhibit to the Registration Statement and to the reference to Bryan Cave Leighton Paisner LLP under the heading “Legal Matters” in the Registration Statement. This opinion is expressed as of the date hereof, and we are under no obligation to advise you of, supplement, or revise our opinion to reflect, any changes (including changes that have retroactive effect) in applicable law or any information, document, certificate, record, statement, representation, covenant or assumption relied upon herein that becomes incorrect or untrue.

 

Very truly yours,

 

/s/ Bryan Cave Leighton Paisner LLP

 

 

EX-101.SCH 4 ohi-20210805.xsd XBRL TAXONOMY EXTENSION SCHEMA 00000001 - Document - Cover link:presentationLink link:calculationLink link:definitionLink EX-101.LAB 5 ohi-20210805_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] EX-101.PRE 6 ohi-20210805_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 7 tm2124195d1_8k_htm.xml IDEA: XBRL DOCUMENT 0000888491 2021-08-05 2021-08-05 iso4217:USD shares iso4217:USD shares 0000888491 false 8-K 2021-08-05 OMEGA HEALTHCARE INVESTORS, INC. MD 1-11316 38-3041398 303 International Circle Suite 200 Hunt Valley MD 21030 410 427-1700 false false false false Common Stock, $.10 par value OHI NYSE false XML 8 R1.htm IDEA: XBRL DOCUMENT v3.21.2
Cover
Aug. 05, 2021
Cover [Abstract]  
Document Type 8-K
Amendment Flag false
Document Period End Date Aug. 05, 2021
Entity File Number 1-11316
Entity Registrant Name OMEGA HEALTHCARE INVESTORS, INC.
Entity Central Index Key 0000888491
Entity Tax Identification Number 38-3041398
Entity Incorporation, State or Country Code MD
Entity Address, Address Line One 303 International Circle
Entity Address, Address Line Two Suite 200
Entity Address, City or Town Hunt Valley
Entity Address, State or Province MD
Entity Address, Postal Zip Code 21030
City Area Code 410
Local Phone Number 427-1700
Written Communications false
Soliciting Material false
Pre-commencement Tender Offer false
Pre-commencement Issuer Tender Offer false
Title of 12(b) Security Common Stock, $.10 par value
Trading Symbol OHI
Security Exchange Name NYSE
Entity Emerging Growth Company false
EXCEL 9 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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end XML 10 Show.js IDEA: XBRL DOCUMENT // Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission. Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105. var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0); e.removeAttribute('id');a.parentNode.appendChild(e)}} if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'} e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}} XML 11 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; white-space: normal; /* word-wrap: break-word; */ } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 12 FilingSummary.xml IDEA: XBRL DOCUMENT 3.21.2 html 1 96 1 false 0 0 false 3 false false R1.htm 00000001 - Document - Cover Sheet http://omegahealthcare.com/role/Cover Cover Cover 1 false false All Reports Book All Reports tm2124195d1_8k.htm ohi-20210805.xsd ohi-20210805_lab.xml ohi-20210805_pre.xml tm2124195d1_ex5-1.htm tm2124195d1_ex8-1.htm http://xbrl.sec.gov/dei/2020-01-31 true false JSON 14 MetaLinks.json IDEA: XBRL DOCUMENT { "instance": { "tm2124195d1_8k.htm": { "axisCustom": 0, "axisStandard": 0, "contextCount": 1, "dts": { "definitionLink": { "remote": [ "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-eedm-def-2020-01-31.xml", "http://xbrl.fasb.org/srt/2020/elts/srt-eedm1-def-2020-01-31.xml" ] }, "inline": { "local": [ "tm2124195d1_8k.htm" ] }, "labelLink": { "local": [ "ohi-20210805_lab.xml" ], "remote": [ "https://xbrl.sec.gov/dei/2020/dei-doc-2020-01-31.xml" ] }, "presentationLink": { "local": [ "ohi-20210805_pre.xml" ] }, "referenceLink": { "remote": [ "https://xbrl.sec.gov/dei/2020/dei-ref-2020-01-31.xml" ] }, "schema": { "local": [ "ohi-20210805.xsd" ], "remote": [ "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd", "http://www.xbrl.org/2003/xl-2003-12-31.xsd", "http://www.xbrl.org/2003/xlink-2003-12-31.xsd", "https://xbrl.sec.gov/dei/2020/dei-2020-01-31.xsd", "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd", "http://www.xbrl.org/2005/xbrldt-2005.xsd", "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd", "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd", "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-gaap-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-roles-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-2020-01-31.xsd", "http://www.xbrl.org/2006/ref-2006-02-27.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-types-2020-01-31.xsd", "http://xbrl.fasb.org/srt/2020/elts/srt-roles-2020-01-31.xsd", "https://xbrl.sec.gov/country/2020/country-2020-01-31.xsd", "http://xbrl.fasb.org/us-gaap/2020/elts/us-types-2020-01-31.xsd", "http://www.xbrl.org/lrr/role/deprecated-2009-12-16.xsd" ] } }, "elementCount": 59, "entityCount": 1, "hidden": { "http://xbrl.sec.gov/dei/2020-01-31": 2, "total": 2 }, "keyCustom": 0, "keyStandard": 96, "memberCustom": 0, "memberStandard": 0, "nsprefix": "ohi", "nsuri": "http://omegahealthcare.com/20210805", "report": { "R1": { "firstAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2124195d1_8k.htm", "contextRef": "From2021-08-05to2021-08-05", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" }, "groupType": "document", "isDefault": "true", "longName": "00000001 - Document - Cover", "role": "http://omegahealthcare.com/role/Cover", "shortName": "Cover", "subGroupType": "", "uniqueAnchor": { "ancestors": [ "span", "b", "p", "body", "html" ], "baseRef": "tm2124195d1_8k.htm", "contextRef": "From2021-08-05to2021-08-05", "decimals": null, "first": true, "lang": "en-US", "name": "dei:DocumentType", "reportCount": 1, "unique": true, "unitRef": null, "xsiNil": "false" } } }, "segmentCount": 0, "tag": { "dei_AmendmentDescription": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Description of changes contained within amended document.", "label": "Amendment Description" } } }, "localname": "AmendmentDescription", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "stringItemType" }, "dei_AmendmentFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.", "label": "Amendment Flag" } } }, "localname": "AmendmentFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AnnualInformationForm": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing an annual information form.", "label": "Annual Information Form" } } }, "localname": "AnnualInformationForm", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_AuditedAnnualFinancialStatements": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag with value true on a form if it is an annual report containing audited financial statements.", "label": "Audited Annual Financial Statements" } } }, "localname": "AuditedAnnualFinancialStatements", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_CityAreaCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Area code of city", "label": "City Area Code" } } }, "localname": "CityAreaCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CountryRegion": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Region code of country", "label": "Country Region" } } }, "localname": "CountryRegion", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_CoverAbstract": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Cover page.", "label": "Cover [Abstract]" } } }, "localname": "CoverAbstract", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "xbrltype": "stringItemType" }, "dei_CurrentFiscalYearEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "End date of current fiscal year in the format --MM-DD.", "label": "Current Fiscal Year End Date" } } }, "localname": "CurrentFiscalYearEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "gMonthDayItemType" }, "dei_DocumentAccountingStandard": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "The basis of accounting the registrant has used to prepare the financial statements included in this filing This can either be 'U.S. GAAP', 'International Financial Reporting Standards', or 'Other'.", "label": "Document Accounting Standard" } } }, "localname": "DocumentAccountingStandard", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "accountingStandardItemType" }, "dei_DocumentAnnualReport": { "auth_ref": [ "r9", "r11", "r12" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an annual report.", "label": "Document Annual Report" } } }, "localname": "DocumentAnnualReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentFiscalPeriodFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Fiscal period values are FY, Q1, Q2, and Q3. 1st, 2nd and 3rd quarter 10-Q or 10-QT statements have value Q1, Q2, and Q3 respectively, with 10-K, 10-KT or other fiscal year statements having FY.", "label": "Document Fiscal Period Focus" } } }, "localname": "DocumentFiscalPeriodFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "fiscalPeriodItemType" }, "dei_DocumentFiscalYearFocus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "This is focus fiscal year of the document report in YYYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.", "label": "Document Fiscal Year Focus" } } }, "localname": "DocumentFiscalYearFocus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "gYearItemType" }, "dei_DocumentPeriodEndDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is YYYY-MM-DD.", "label": "Document Period End Date" } } }, "localname": "DocumentPeriodEndDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentPeriodStartDate": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The start date of the period covered in the document, in YYYY-MM-DD format.", "label": "Document Period Start Date" } } }, "localname": "DocumentPeriodStartDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentQuarterlyReport": { "auth_ref": [ "r10" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as an quarterly report.", "label": "Document Quarterly Report" } } }, "localname": "DocumentQuarterlyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentRegistrationStatement": { "auth_ref": [ "r18" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a registration statement.", "label": "Document Registration Statement" } } }, "localname": "DocumentRegistrationStatement", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentShellCompanyEventDate": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Date of event requiring a shell company report.", "label": "Document Shell Company Event Date" } } }, "localname": "DocumentShellCompanyEventDate", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "dateItemType" }, "dei_DocumentShellCompanyReport": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true for a Shell Company Report pursuant to section 13 or 15(d) of the Exchange Act.", "label": "Document Shell Company Report" } } }, "localname": "DocumentShellCompanyReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentTransitionReport": { "auth_ref": [ "r13" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a form used as a transition report.", "label": "Document Transition Report" } } }, "localname": "DocumentTransitionReport", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_DocumentType": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.", "label": "Document Type" } } }, "localname": "DocumentType", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "submissionTypeItemType" }, "dei_DocumentsIncorporatedByReferenceTextBlock": { "auth_ref": [ "r1" ], "lang": { "en-us": { "role": { "documentation": "Documents incorporated by reference.", "label": "Documents Incorporated by Reference [Text Block]" } } }, "localname": "DocumentsIncorporatedByReferenceTextBlock", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "textBlockItemType" }, "dei_EntityAddressAddressLine1": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 1 such as Attn, Building Name, Street Name", "label": "Entity Address, Address Line One" } } }, "localname": "EntityAddressAddressLine1", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine2": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 2 such as Street or Suite number", "label": "Entity Address, Address Line Two" } } }, "localname": "EntityAddressAddressLine2", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressAddressLine3": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Address Line 3 such as an Office Park", "label": "Entity Address, Address Line Three" } } }, "localname": "EntityAddressAddressLine3", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCityOrTown": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the City or Town", "label": "Entity Address, City or Town" } } }, "localname": "EntityAddressCityOrTown", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressCountry": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "ISO 3166-1 alpha-2 country code.", "label": "Entity Address, Country" } } }, "localname": "EntityAddressCountry", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "countryCodeItemType" }, "dei_EntityAddressPostalZipCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Code for the postal or zip code", "label": "Entity Address, Postal Zip Code" } } }, "localname": "EntityAddressPostalZipCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityAddressStateOrProvince": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Name of the state or province.", "label": "Entity Address, State or Province" } } }, "localname": "EntityAddressStateOrProvince", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "stateOrProvinceItemType" }, "dei_EntityBankruptcyProceedingsReportingCurrent": { "auth_ref": [ "r4" ], "lang": { "en-us": { "role": { "documentation": "For registrants involved in bankruptcy proceedings during the preceding five years, the value Yes indicates that the registrant has filed all documents and reports required to be filed by Section 12, 13 or 15(d) of the Securities Exchange Act of 1934 subsequent to the distribution of securities under a plan confirmed by a court; the value No indicates the registrant has not. Registrants not involved in bankruptcy proceedings during the preceding five years should not report this element.", "label": "Entity Bankruptcy Proceedings, Reporting Current" } } }, "localname": "EntityBankruptcyProceedingsReportingCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityCentralIndexKey": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.", "label": "Entity Central Index Key" } } }, "localname": "EntityCentralIndexKey", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "centralIndexKeyItemType" }, "dei_EntityCommonStockSharesOutstanding": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.", "label": "Entity Common Stock, Shares Outstanding" } } }, "localname": "EntityCommonStockSharesOutstanding", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "sharesItemType" }, "dei_EntityCurrentReportingStatus": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' whether registrants (1) have filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that registrants were required to file such reports), and (2) have been subject to such filing requirements for the past 90 days. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Current Reporting Status" } } }, "localname": "EntityCurrentReportingStatus", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityEmergingGrowthCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate if registrant meets the emerging growth company criteria.", "label": "Entity Emerging Growth Company" } } }, "localname": "EntityEmergingGrowthCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityExTransitionPeriod": { "auth_ref": [ "r17" ], "lang": { "en-us": { "role": { "documentation": "Indicate if an emerging growth company has elected not to use the extended transition period for complying with any new or revised financial accounting standards.", "label": "Elected Not To Use the Extended Transition Period" } } }, "localname": "EntityExTransitionPeriod", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityFileNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.", "label": "Entity File Number" } } }, "localname": "EntityFileNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "fileNumberItemType" }, "dei_EntityFilerCategory": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicate whether the registrant is one of the following: Large Accelerated Filer, Accelerated Filer, Non-accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.", "label": "Entity Filer Category" } } }, "localname": "EntityFilerCategory", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "filerCategoryItemType" }, "dei_EntityIncorporationStateCountryCode": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Two-character EDGAR code representing the state or country of incorporation.", "label": "Entity Incorporation, State or Country Code" } } }, "localname": "EntityIncorporationStateCountryCode", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "edgarStateCountryItemType" }, "dei_EntityInteractiveDataCurrent": { "auth_ref": [ "r15" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit such files).", "label": "Entity Interactive Data Current" } } }, "localname": "EntityInteractiveDataCurrent", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityPrimarySicNumber": { "auth_ref": [ "r12" ], "lang": { "en-us": { "role": { "documentation": "Primary Standard Industrial Classification (SIC) Number for the Entity.", "label": "Entity Primary SIC Number" } } }, "localname": "EntityPrimarySicNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "sicNumberItemType" }, "dei_EntityPublicFloat": { "auth_ref": [], "crdr": "credit", "lang": { "en-us": { "role": { "documentation": "The aggregate market value of the voting and non-voting common equity held by non-affiliates computed by reference to the price at which the common equity was last sold, or the average bid and asked price of such common equity, as of the last business day of the registrant's most recently completed second fiscal quarter.", "label": "Entity Public Float" } } }, "localname": "EntityPublicFloat", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "monetaryItemType" }, "dei_EntityRegistrantName": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.", "label": "Entity Registrant Name" } } }, "localname": "EntityRegistrantName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_EntityShellCompany": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the registrant is a shell company as defined in Rule 12b-2 of the Exchange Act.", "label": "Entity Shell Company" } } }, "localname": "EntityShellCompany", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntitySmallBusiness": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "Indicates that the company is a Smaller Reporting Company (SRC).", "label": "Entity Small Business" } } }, "localname": "EntitySmallBusiness", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_EntityTaxIdentificationNumber": { "auth_ref": [ "r14" ], "lang": { "en-us": { "role": { "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.", "label": "Entity Tax Identification Number" } } }, "localname": "EntityTaxIdentificationNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "employerIdItemType" }, "dei_EntityVoluntaryFilers": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act.", "label": "Entity Voluntary Filers" } } }, "localname": "EntityVoluntaryFilers", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_EntityWellKnownSeasonedIssuer": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Indicate 'Yes' or 'No' if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Is used on Form Type: 10-K, 10-Q, 8-K, 20-F, 6-K, 10-K/A, 10-Q/A, 20-F/A, 6-K/A, N-CSR, N-Q, N-1A.", "label": "Entity Well-known Seasoned Issuer" } } }, "localname": "EntityWellKnownSeasonedIssuer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "yesNoItemType" }, "dei_Extension": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Extension number for local phone number.", "label": "Extension" } } }, "localname": "Extension", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_LocalPhoneNumber": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Local phone number for entity.", "label": "Local Phone Number" } } }, "localname": "LocalPhoneNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "normalizedStringItemType" }, "dei_NoTradingSymbolFlag": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true only for a security having no trading symbol.", "label": "No Trading Symbol Flag" } } }, "localname": "NoTradingSymbolFlag", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_OtherReportingStandardItemNumber": { "auth_ref": [ "r11" ], "lang": { "en-us": { "role": { "documentation": "\"Item 17\" or \"Item 18\" specified when the basis of accounting is neither US GAAP nor IFRS.", "label": "Other Reporting Standard Item Number" } } }, "localname": "OtherReportingStandardItemNumber", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "otherReportingStandardItemNumberItemType" }, "dei_PreCommencementIssuerTenderOffer": { "auth_ref": [ "r5" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.", "label": "Pre-commencement Issuer Tender Offer" } } }, "localname": "PreCommencementIssuerTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_PreCommencementTenderOffer": { "auth_ref": [ "r6" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.", "label": "Pre-commencement Tender Offer" } } }, "localname": "PreCommencementTenderOffer", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_Security12bTitle": { "auth_ref": [ "r0" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(b) registered security.", "label": "Title of 12(b) Security" } } }, "localname": "Security12bTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_Security12gTitle": { "auth_ref": [ "r3" ], "lang": { "en-us": { "role": { "documentation": "Title of a 12(g) registered security.", "label": "Title of 12(g) Security" } } }, "localname": "Security12gTitle", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "securityTitleItemType" }, "dei_SecurityExchangeName": { "auth_ref": [ "r2" ], "lang": { "en-us": { "role": { "documentation": "Name of the Exchange on which a security is registered.", "label": "Security Exchange Name" } } }, "localname": "SecurityExchangeName", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "edgarExchangeCodeItemType" }, "dei_SecurityReportingObligation": { "auth_ref": [ "r7" ], "lang": { "en-us": { "role": { "documentation": "15(d), indicating whether the security has a reporting obligation under that section of the Exchange Act.", "label": "Security Reporting Obligation" } } }, "localname": "SecurityReportingObligation", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "securityReportingObligationItemType" }, "dei_SolicitingMaterial": { "auth_ref": [ "r8" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.", "label": "Soliciting Material" } } }, "localname": "SolicitingMaterial", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" }, "dei_TradingSymbol": { "auth_ref": [], "lang": { "en-us": { "role": { "documentation": "Trading symbol of an instrument as listed on an exchange.", "label": "Trading Symbol" } } }, "localname": "TradingSymbol", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "tradingSymbolItemType" }, "dei_WrittenCommunications": { "auth_ref": [ "r16" ], "lang": { "en-us": { "role": { "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.", "label": "Written Communications" } } }, "localname": "WrittenCommunications", "nsuri": "http://xbrl.sec.gov/dei/2020-01-31", "presentation": [ "http://omegahealthcare.com/role/Cover" ], "xbrltype": "booleanItemType" } }, "unitCount": 3 } }, "std_ref": { "r0": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b" }, "r1": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-23" }, "r10": { "Name": "Form 10-Q", "Number": "240", "Publisher": "SEC", "Section": "308", "Subsection": "a" }, "r11": { "Name": "Form 20-F", "Number": "249", "Publisher": "SEC", "Section": "220", "Subsection": "f" }, "r12": { "Name": "Form 40-F", "Number": "249", "Publisher": "SEC", "Section": "240", "Subsection": "f" }, "r13": { "Name": "Forms 10-K, 10-Q, 20-F", "Number": "240", "Publisher": "SEC", "Section": "13", "Subsection": "a-1" }, "r14": { "Name": "Regulation 12B", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "b-2" }, "r15": { "Name": "Regulation S-T", "Number": "232", "Publisher": "SEC", "Section": "405" }, "r16": { "Name": "Securities Act", "Number": "230", "Publisher": "SEC", "Section": "425" }, "r17": { "Name": "Securities Act", "Number": "7A", "Publisher": "SEC", "Section": "B", "Subsection": "2" }, "r18": { "Name": "Securities Act", "Number": "Section", "Publisher": "SEC", "Section": "12" }, "r2": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "d1-1" }, "r3": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12", "Subsection": "g" }, "r4": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "12, 13, 15d" }, "r5": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "13e", "Subsection": "4c" }, "r6": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14d", "Subsection": "2b" }, "r7": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "15", "Subsection": "d" }, "r8": { "Name": "Exchange Act", "Number": "240", "Publisher": "SEC", "Section": "14a", "Subsection": "12" }, "r9": { "Name": "Form 10-K", "Number": "249", "Publisher": "SEC", "Section": "310" } }, "version": "2.1" } ZIP 15 0001104659-21-100781-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001104659-21-100781-xbrl.zip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end